Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Laboratorios Cinfa S.A. en Spain

O
OLMESARTAN/HYDROCHLOROTHIAZIDE CINFA 20 mg/12.5 mg FILM-COATED TABLETS
Dosage form:  TABLET, 20 mg / 12.5 mg per tablet
Active substance:  olmesartan medoxomil and diuretics
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OLMESARTAN/HYDROCHLOROTHIAZIDE CINFA 20 mg/25 mg FILM-COATED TABLETS
Dosage form:  TABLET, 20 mg / 25 mg per tablet
Active substance:  olmesartan medoxomil and diuretics
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OLMESARTAN/HYDROCHLOROTHIAZIDE CINFA 40 mg/12.5 mg FILM-COATED TABLETS
Dosage form:  TABLET, 40 mg / 12.5 mg per tablet
Active substance:  olmesartan medoxomil and diuretics
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OLMESARTAN/HYDROCHLOROTHIAZIDE CINFA 40 mg/25 mg FILM-COATED TABLETS
Dosage form:  TABLET, 40 mg / 25 mg per tablet
Active substance:  olmesartan medoxomil and diuretics
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OMEKASTE 20 mg GASTRO-RESISTANT HARD CAPSULES
Dosage form:  CAPSULE, 20 mg
Active substance:  omeprazole
Manufacturer:  Laboratorios Cinfa S.A.
Prescription not required
OMEPRAZOL CINFA 20 mg HARD GASTRO-RESISTANT CAPSULES
Dosage form:  CAPSULE, 20 mg
Active substance:  omeprazole
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OMEPRAZOL CINFA 40 mg HARD GASTRO-RESISTANT CAPSULES
Dosage form:  CAPSULE, 40 mg
Active substance:  omeprazole
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OMEPRAZOL CINFAMED 20 mg HARD GASTRORESISTENT CAPSULES
Dosage form:  CAPSULE, 20 mg omeprazole
Active substance:  omeprazole
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OMEPRAZOL CINFAMED 40 mg HARD GASTRORESISTENT CAPSULES
Dosage form:  CAPSULE, 40 mg
Active substance:  omeprazole
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OPTIALERG 5 mg/mL + 0.25 mg/mL EYE DROPS SOLUTION
Dosage form:  EYEDROP, 5 mg/ml + 0.25 mg/ml
Active substance:  naphazoline, combinations
Manufacturer:  Laboratorios Cinfa S.A.
Prescription not required
OPTISPRING 0.5 mg/ml EYE DROPS SOLUTION
Dosage form:  EYEDROP, 0.5 mg/ml
Active substance:  tetryzoline
Manufacturer:  Laboratorios Cinfa S.A.
Prescription not required
OPTISPRING 0.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS
Dosage form:  EYE DROP, 0.5 mg/ml
Active substance:  tetryzoline
Manufacturer:  Laboratorios Cinfa S.A.
Prescription not required
ORLISTAT CINFA 120 mg HARD CAPSULES
Dosage form:  CAPSULE, 120 mg
Active substance:  orlistat
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OTILONIO CINFA 40 mg FILM-COATED TABLETS
Dosage form:  TABLET, 40 mg
Active substance:  otilonium bromide
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXCARBAZEPINE CINFA 300 mg FILM-COATED TABLETS
Dosage form:  TABLET, 300 mg
Active substance:  oxcarbazepine
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXCARBAZEPINE CINFA 600 mg FILM-COATED TABLETS
Dosage form:  TABLET, 600 mg
Active substance:  oxcarbazepine
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXICODONE/NALOXONE CINFA 10 mg/5 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 10 mg/5 mg
Active substance:  oxycodone and naloxone
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXICODONE/NALOXONE CINFA 20 mg/10 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 20 mg/10 mg
Active substance:  oxycodone and naloxone
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXICODONE/NALOXONE CINFA 40 mg/20 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 40 mg/20 mg
Active substance:  oxycodone and naloxone
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
OXICODONE/NALOXONE CINFA 5 mg/2.5 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 5 mg/2.5 mg
Active substance:  oxycodone and naloxone
Manufacturer:  Laboratorios Cinfa S.A.
Prescription required
2
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media